Andrey B. Komissarov

Author

Also Known As

A B Komissarov, A. B. Komissarov, A. Komissarov, A.B. KOMISSAROV, A.B. Komissarov, A.V. KOMISSAROV, Andrey B Komissarov, Andrey B. Komissarov, Andrey Borisovich Komissarov, Andrey Komissarov

152

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Research Institute of Influenza First Pavlov State Medical University of St. Petersburg Skolkovo Institute of Science and Technology Institute for Information Transmission Problems Ministry of Health of the Russian Federation

About

Andrey B. Komissarov is an author at Research Institute of Influenza specializing in medicine, covid-19, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	679
2	Epidemiology	13	14	625
3	Public Health	9	9	432
4	Global Health	6	6	352
5	Geography	1	1	260

Andrey B. Komissarov

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 Erik Alm, Eeva Broberg, Thomas R. Connor, Eurosurveillance Viral DiagnosticsEarth ScienceCovid-19Pathogen DiscoveryViral Evolution	2020	260
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants Vladimir А. Gushchin, Inna V. Dolzhikova, Andrei E. Siniavin, Vaccines Rbd DomainImmunologyVaccine HesitancyCovid-19Vaccine Target	2021	118
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia Andrey B. Komissarov, Ksenia R. Safina, Sofya K. Garushyants, Nature Communications	2021	112
Unlocking capacities of genomics for the COVID-19 response and future pandemics Sergey Knyazev, Karishma Chhugani, Varuni Sarwal, Nature Methods	2022	64
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector Franco Maria Venanzi, Victor Shifrin, Michael Y. Sherman, Oncotarget	2013	62
Arbovirus researchers unite: expanding genomic surveillance for an urgent global need Gabriel Luz Wallau, Ngu Njei Abanda, Adriano Abbud, The Lancet Global Health	2023	61
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 Oksana V. Stanevich, Evgeniia Alekseeva, Maria V. Sergeeva, Nature Communications	2023	59
COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants A. Yu. Popova, K. Khafizov, S. V. Ugleva, Journal of microbiology epidemiology immunobiology Viral EvolutionRussian FederationVirus EpidemiologyEmerging Infectious DiseasesMedicine	2022	43
Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation Daria Danilenko, Andrey B. Komissarov, Maria Pisareva, Viruses	2023	35
Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors Yulia A. Chapygina, Viktoria Dvornichenko, Natalia V. Zhukova, Oncotarget ImmunologyImmunoeditingPathologyMetronomic ChemotherapyImmunotherapy	2017	34

Page 1